Pharmacological induction of fetal hemoglobin in sickle cell disease and β-thalassemia
- 1 October 2001
- journal article
- review article
- Published by Elsevier in Seminars in Hematology
- Vol. 38 (4) , 367-373
- https://doi.org/10.1016/s0037-1963(01)90031-9
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patientsThe Hematology Journal, 2000
- Hydroxyurea Therapy in ThalassemiaaAnnals of the New York Academy of Sciences, 1998
- Erythroid Progenitor Proliferation is Stimulated by Phenoxyacetic and Phenylalkyl AcidsBlood Cells, Molecules, and Diseases, 1996
- Effect of Hydroxyurea on the Frequency of Painful Crises in Sickle Cell AnemiaNew England Journal of Medicine, 1995
- Pharmacologic treatment of thalassemia intermedia with hydroxyureaThe Journal of Pediatrics, 1994
- Hematologic Responses of Patients with Sickle Cell Disease to Treatment with HydroxyureaNew England Journal of Medicine, 1990
- Levels of Fetal Hemoglobin Necessary for Treatment of Sickle Cell DiseaseNew England Journal of Medicine, 1988
- Delay in the Fetal Globin Switch in Infants of Diabetic MothersNew England Journal of Medicine, 1985
- Augmentation of Fetal-Hemoglobin Production in Anemic Monkeys by HydroxyureaNew England Journal of Medicine, 1984
- THE SIGNIFICANCE OF THE PAUCITY OF SICKLE CELLS IN NEWBORN NEGRO INFANTSThe Lancet Healthy Longevity, 1948